This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Shohei Koide, PhD
Professor of Biologics Design, Department of Biochemistry and Molecular Pharmacology at NYU Grossman School of Medicine
Speaker

Profile

Shohei Koide, Ph.D. is a synthetic protein scientist. His research integrates mechanistic biochemistry and directed evolution to create highly functional but still simple proteins. He is the inventor of the FN3 Monobody technology, and has made important contribution to synthetic antibody technologies. He has pioneered many applications of synthetic binding proteins to biology, chemistry and medicine. Previously he was Professor at University of Chicago and at University of Rochester School of Medicine and Dentistry. He is an elected fellow of the AAAS and the National Academy of Inventors. He is a co-founder of Aethon Therapeutics.

Agenda Sessions

  • Chairperson’s Remarks

    13:55
  • Targeting Intracellular Cancer Drivers with Monobodies

    16:30